Market Overview

Baird Initiates Coverage on Gilead Sciences, Inc. at Outperform, Announces $86.00 PT

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for GILD

DateFirmActionFromTo
Sep 2017RBC CapitalInitiates Coverage OnOutperform
Aug 2017ArgusUpgradesHoldBuy
Aug 2017Credit SuisseMaintainsOutperform

View More Analyst Ratings for GILD
View the Latest Analyst Ratings

Posted-In: News Analyst Ratings

 

Related Articles (GILD)

Loading...